Word

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Status

Dead

Status Code

602

Status Date

Thursday, April 7, 2022

Serial Number

88730797

Mark Type

4000

Filing Date

Tuesday, December 17, 2019

Abandoned Date

Friday, March 4, 2022

Trademark Owner History

Angiex, Inc.

Classifications

42 Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

NUCLEAR DELIVERED ANTI BODY DRUG CONJUGATES

Trademark Events

Apr 7, 2022

Abandonment Notice E-Mailed - Failure To Respond

Apr 7, 2022

Abandonment - Failure To Respond Or Late Response

Sep 3, 2021

Notification Of Final Refusal Emailed

Sep 3, 2021

Final Refusal E-Mailed

Sep 3, 2021

Final Refusal Written

Aug 16, 2021

Teas/Email Correspondence Entered

Aug 16, 2021

Correspondence Received In Law Office

Aug 9, 2021

Teas Response To Office Action Received

Feb 10, 2021

Notification Of Non-Final Action E-Mailed

Feb 10, 2021

Non-Final Action E-Mailed

Feb 10, 2021

Non-Final Action Written

Jan 25, 2021

Teas/Email Correspondence Entered

Jan 25, 2021

Correspondence Received In Law Office

Jan 22, 2021

Assigned To Lie

Oct 12, 2020

Teas Response To Office Action Received

Apr 14, 2020

Notice Of Acceptance Of Amendment To Allege Use E-Mailed

Apr 13, 2020

Notification Of Non-Final Action E-Mailed

Apr 13, 2020

Non-Final Action E-Mailed

Apr 13, 2020

Non-Final Action Written

Apr 12, 2020

Use Amendment Accepted

Apr 2, 2020

Teas/Email Correspondence Entered

Apr 1, 2020

Correspondence Received In Law Office

Apr 1, 2020

Teas Response To Office Action Received

Apr 2, 2020

Amendment To Use Processing Complete

Apr 2, 2020

Use Amendment Filed

Apr 1, 2020

Teas Amendment Of Use Received

Mar 17, 2020

Notification Of Non-Final Action E-Mailed

Mar 17, 2020

Non-Final Action E-Mailed

Mar 17, 2020

Non-Final Action Written

Mar 16, 2020

Assigned To Examiner

Dec 20, 2019

New Application Office Supplied Data Entered

Dec 20, 2019

New Application Entered